Jennifer Cheng, Ph.D., J.D.

Jennifer Cheng, Ph.D., J.D. is Adverum’s vice president and general counsel and has led the legal function since joining the Company in 2015. Prior to Adverum, Dr. Cheng was a patent counsel with Allergan, where she was responsible for developing and implementing patent strategy. She also served as the senior patent counsel for MAP Pharmaceuticals until it was acquired by Allergan in 2013. Previously, Dr. Cheng was the manager of intellectual property for Solazyme, Inc. and a patent counsel at Raven Biotechnologies. Dr. Cheng began her career at Genentech, where she was a research associate. She received a B.A. in Molecular and Cellular Biology as well as in Rhetoric from the University of California, Berkeley. She earned a Ph.D. in tumor cell biology and molecular medicine from Northwestern University and a J.D. from Santa Clara University School of Law.